Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
Contacts
シアトル
+1 415 439 1799シアトル
Capabilities
Suggested News & Insights
Sidley's 2026 San Diego Clinical Trial SeriesThursday, January 29, 2026 | Thursday, March 12, 2026 | Tuesday, April 21, 2026U.S. Clinical Trial Design & Execution RisksThursday, January 29, 2026At the Table: Serving Up a Lively Discussion with the FDA, USDA, and HHSWednesday, January 28, 2026Delaware Supreme Court Makes Earnouts Less Risky For Buyers Earnout Decision Partially Reversed Because Buyer Did Not Have to Pursue an Alternative Regulatory PathwayJanuary 27, 2026Medical Products Market Access: Favorable Advisory Opinion Reaffirms Discounting FlexibilitiesJanuary 21, 2026FY 2025 FCA Settlements and Judgments Statistics Show Highest Recoveries EverJanuary 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory